Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Incannex Healthcare Inc.

Release Phase 2 top-line results from U.S. portion of RePOSA clinical study

Delivered after the deadline (30 days after the deadline)

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
4 Feb 2025
Due
30 Jun 2025
Delivered
30 Jul 2025
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“A top-line readout from the U.S. Phase 2 portion is anticipated in the first half of 2025.”

What we found

Evidence strength A What the grades mean

Incannex guided to 'H1 2025' in February but shifted guidance to July 2025 by May, ultimately releasing RePOSA Phase 2 topline results on July 30, 2025.

Checked 12 Sep 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Commercial launch
Indicative materiality
Medium rules
Action
Release
Language
Expected (“expects”, “plans”)

How this entry was checked

  1. Commitment recordedRecorded from the company's filing.
  2. First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesGemini (Google) re-read the evidence blind and read it as “Not met”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and reads it as “no_evidence”.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Incannex Healthcare Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2025-IXHL-000178 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.